Drug Discovery for Infectious Diseases—Second Edition

Dear Colleagues,

Infectious diseases encompass a wide range of diseases caused by viruses, bacteria, fungi and parasites, all of which have serious consequences for human health. The rapid emergence of new viral and parasitic diseases, as well as the spread of antimicrobial resistance, is also putting drug research at a disadvantage, posing a challenge to the biomedical research field to develop new drugs and drug innovation strategies to keep pace with these new needs. Recent pandemics in particular highlight the need for novel antiviral drugs in several areas of human and animal health.

This Special Issue welcomes reviews and papers describing host-entry and reproduction of the pathogen and pathomechanism of diseases at the molecular level, as well as those reporting on the discovery of new drug candidates that affect these processes. New mechanisms of drug action and new drug targets are esecially promising approaches, which, besides their significance, may have potential applications in other areas. Approaches based on the ‘One Health’ principle are also encouraged. Innovative drug discovery strategies, including repositioning stategies from other pharmacological areas, drug combinations or multiple-targeting ligands, as well as new drug formulations for improved ADME, also represent suitable subjects of submitted papers.

Dr. Ákos Jerzsele
Dr. Dóra Kovács
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• human drug discovery
• antiviral, antibacterial, antifungal, antiparasitic
• infectious pathomechanisms
• drug discovery strategy
• one health principle

• Drug Discovery for Infectious Diseases in Biomedicines (11 articles)